Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Deben, Christophe
*MAILING ADDRESS
Rubensstraat 69
*CITY
Kontich
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Belgium
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
2550
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
individual
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF CITIZENSHIP
Belgium
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
009
*IDENTIFICATION
Downloadable software as a Medical Device (SaMD); Downloadable medical software; Downloadable medical imaging software; Downloadable medical
and scientific analysis software; Downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development;
Downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable computer
software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable software for analyzing microscopic
images; Downloadable cloud computing software for analyzing microscopic images; Downloadable computer software platforms for analysing microscopic images; All the aforesaid in particular in the field
of cancer research, cancer screening, cancer treatment and cancer diagnosis.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Providing online, non-downloadable software for use as a medical device; Platform as a Service (PAAS) featuring computer software platforms
for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Cloud computing featuring software for use in medical imaging,
image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing temporary use of on-line non-downloadable cloud computing software for
medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing on-line non-downloadable software for medical imaging, image
analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Software as a service (SAAS) services featuring software for medical imaging, image analysis,
image storage and image transfer; Software as a service (SAAS) services featuring software for drug screening, testing of pharmaceuticals and drug development; Platform as a Service (PAAS) featuring
computer software platforms for analyzing microscopic images; Cloud computing featuring software for use in analysing microscopic images; Providing temporary use of on-line on-downloadable cloud
computing software for analysing microscopic images; Providing on-line non-downloadable software for analyzing microscopic images; Software as a service (SAAS) services featuring software for
analyzing microscopic images; Medical laboratory services; Medical and scientific research in the field of medical imaging, image analysis, drug screening, testing of pharmaceuticals and drug
development; Drug screening for scientific research purposes; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Medical and scientific research, namely,
conducting clinical trials for others; All the aforesaid also using artificial intelligence; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and
cancer diagnosis.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Associate Attorney, Fresh IP PLC, CO Bar No.: 47934
SIGNATORY'S PHONE NUMBER
866-913-3499
DATE SIGNED
12/14/2022
SIGNATURE METHOD
Signed directly within the form
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97716665
Filing Date:12/14/2022
To the Commissioner for Trademarks:
MARK: ORBITS (Standard Characters, see mark)
The literal element of the mark consists of ORBITS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Christophe Deben, a citizen of Belgium, having an address of
Rubensstraat 69
Kontich 2550
Belgium
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 009: Downloadable software as a Medical Device (SaMD); Downloadable medical software; Downloadable medical imaging software; Downloadable medical and scientific analysis
software; Downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable cloud computing
software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable computer software platforms for medical
imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable software for analyzing microscopic images; Downloadable cloud
computing software for analyzing microscopic images; Downloadable computer software platforms for analysing microscopic images; All the aforesaid in particular in the field of cancer research, cancer
screening, cancer treatment and cancer diagnosis.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 018727021, filed 07/01/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
European Union Trademark - EUTM registration number 018727021, and/or proof of renewal, registered 12/10/2022 with a renewal date of __________ and an expiration date of 07/01/2032, and translation
thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 042: Providing online, non-downloadable software for use as a medical device; Platform as a Service (PAAS) featuring computer software platforms for medical imaging, image
analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Cloud computing featuring software for use in medical imaging, image analysis, image storage,
image transfer, drug screening, testing of pharmaceuticals and drug development; Providing temporary use of on-line non-downloadable cloud computing software for medical imaging, image analysis,
image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing on-line non-downloadable software for medical imaging, image analysis, image storage, image
transfer, drug screening, testing of pharmaceuticals and drug development; Software as a service (SAAS) services featuring software for medical imaging, image analysis, image storage and image
transfer; Software as a service (SAAS) services featuring software for drug screening, testing of pharmaceuticals and drug development; Platform as a Service (PAAS) featuring computer software
platforms for analyzing microscopic images; Cloud computing featuring software for use in analysing microscopic images; Providing temporary use of on-line on-downloadable cloud computing software for
analysing microscopic images; Providing on-line non-downloadable software for analyzing microscopic images; Software as a service (SAAS) services featuring software for analyzing microscopic images;
Medical laboratory services; Medical and scientific research in the field of medical imaging, image analysis, drug screening, testing of pharmaceuticals and drug development; Drug screening for
scientific research purposes; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for
others; All the aforesaid also using artificial intelligence; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on European Union Trademark - EUTM application number 018727021, filed 07/01/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
European Union Trademark - EUTM registration number 018727021, and/or proof of renewal, registered 12/10/2022 with a renewal date of __________ and an expiration date of 07/01/2032, and translation
thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
The owner's/holder's proposed attorney information: Clifford D. Hyra. Other appointed attorneys are Fresh IP PLC. Clifford D. Hyra of Fresh IP PLC, is a member of the XX bar, admitted to the bar
in XXXX, bar membership no. XXX, and the attorney(s) is located at
11710 Plaza America Drive Suite 2000
Reston, Virginia 20190
United States
866-913-3499(phone)
866-913-3501(fax)
cliff@freship.com
The docket/reference number is HDCPA-T467US.
Clifford D. Hyra submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant hereby appoints Clifford D. Hyra of Fresh IP PLC
11710 Plaza America Drive Suite 2000
Reston Virginia 20190
United States
866-913-3499(phone)
866-913-3501(fax)
cliff@freship.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Micah Gunn/ Date: 12/14/2022
Signatory's Name: Micah Gunn
Signatory's Position: Associate Attorney, Fresh IP PLC, CO Bar No.: 47934
Signatory's Phone Number: 866-913-3499
Signature method: Signed directly within the form
Payment Sale Number: 97716665
Payment Accounting Date: 12/14/2022
Serial Number: 97716665
Internet Transmission Date: Wed Dec 14 09:23:10 ET 2022
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20221214092311931
492-97716665-8508ab25581bb7fe157c28d2a68
fb66f042e2ef8b591c5e7ffd4d6688bd739fa8a-
CC-23103169-20221214091939218168